Drug Type Biosimilar, Fusion protein |
Synonyms Etanercept Biosimilar (Lupin Ltd), Nepexto, エタネルセプト(遺伝子組換え)(株式会社陽進堂) + [4] |
Target |
Mechanism LTα inhibitors(Tumor necrosis factor β inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (26 Mar 2019), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Etanercept biosimilar(Lupin Ltd) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ankylosing Spondylitis | EU | 20 May 2020 | |
Ankylosing Spondylitis | IS | 20 May 2020 | |
Ankylosing Spondylitis | LI | 20 May 2020 | |
Ankylosing Spondylitis | NO | 20 May 2020 | |
Arthritis, Psoriatic | EU | 20 May 2020 | |
Arthritis, Psoriatic | IS | 20 May 2020 | |
Arthritis, Psoriatic | LI | 20 May 2020 | |
Arthritis, Psoriatic | NO | 20 May 2020 | |
Axial Spondyloarthritis | EU | 20 May 2020 | |
Axial Spondyloarthritis | IS | 20 May 2020 | |
Axial Spondyloarthritis | LI | 20 May 2020 | |
Axial Spondyloarthritis | NO | 20 May 2020 | |
Enthesitis-Related Arthritis | EU | 20 May 2020 | |
Enthesitis-Related Arthritis | IS | 20 May 2020 | |
Enthesitis-Related Arthritis | LI | 20 May 2020 | |
Enthesitis-Related Arthritis | NO | 20 May 2020 | |
Plaque psoriasis | EU | 20 May 2020 | |
Plaque psoriasis | IS | 20 May 2020 | |
Plaque psoriasis | LI | 20 May 2020 | |
Plaque psoriasis | NO | 20 May 2020 |
Phase 3 | - | yyqkkbpjte(zotujcokdi) = qqugjvxbxe dhrljpcmsk (dwggvriodj ) View more | Positive | 02 Jun 2021 | |||
Reference Product (RP) | yyqkkbpjte(zotujcokdi) = jawmnrdqwp dhrljpcmsk (dwggvriodj ) View more | ||||||
Phase 3 | 528 | gvvcyzvpfb(gifurzkfbd) = whwjpywehp rhamjkngsp (brnuyogfrg ) | Positive | 12 Jun 2019 |